-
Dana-Farber researchers awarded CLL Society grants to expand treatment options for CLL
Chronic lymphocytic leukemia (CLL) research at Dana-Farber Cancer Institute is advancing through two grants from the CLL Society totaling $600,000.
-
The Ellison Foundation fuels innovation as an enduring partner
With renewed funding from The Ellison Foundation, Bill Lotter, PhD, Eliezer Van Allen, MD, and Robbie Majzner, MD, are conducting pioneering work with the potential to advance research and treatment across multiple cancer types.
-
Tina’s Wish opens new doors in ovarian cancer research
Ovarian cancer remains one of the most devastating cancers due to diagnosis often coming at a later stage.
-
Pfizer supports innovative projects to guide care for challenging cancers
In 2025, Pfizer made generous grants totaling $633,405 to advance promising projects led by Rachel Freedman, MD, MPH; Terri Jabaley, PhD, Sarah Sammons, MD, and Adrienne Waks, MD.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.